Skip to main content
. 2012 Jul 31;17(8):1090–1099. doi: 10.1634/theoncologist.2011-0450

Table 2.

Hedgehog pathway inhibitors currently in clinical trials in cancer

graphic file with name onc00812-1136-t02.jpg

Abbreviations: BCC, basal cell carcinoma; FOLFIRI, 5-fluorouracil/leucovorin and irinotecan; FOLFORINOX, 5-fluorouracil/leucovorin, irinotecan, and oxaliplatin; FOLFOX, 5-fluorouracil/leucovorin and oxaliplatin.